TB-COVID Bidirectional Screening
- Read more about TB-COVID Bidirectional Screening
- Log in to post comments
Default status of page at the time it is added for creation.
Why important, how is it done,
May use Nikshay screen recordings available
Second-line Line Probe Assay (SL-LPA) is a LPA to detect resistance to the second-line anti-TB drugs. This test is recommended for identifying TB patients with Multidrug-resistance (MDR) or rifampicin-resistance and those who can be placed on the shorter MDR-TB regimen.
The SL-LPA produces results in just 24-48 hours.
GeneXpert MTB/RIF Assay is also called Cartridge Based Nucleic Acid Technology (CBNAAT).